Product Details
| Product Name: Edoxaban | CAS No.: 480449-70-5 |
| EC-No.: 859-181-7 | Min. Order: 1Kg/Bag |
| Purity: 99% up, High Density | Supply Ability: 20 tons |
| Release date: 2026/01/16 |
Product Information
| Prodcut name | Edoxaban |
| Synonyms | N-(5-Chloro-2-pyridinyl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide;Savaysa;N1-(5-chloropyridin-2-yl)-N2-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide;DU-176b;Lixiana; |
| MOQ | 1KG |
| CAS | 480449-70-5 |
| Appearance | White |
| Molecular Formula | C24H30ClN7O4S |
| Molecular Weight | 548.057 |
| Assay | 99% |
| Application | Pharma grade |
| Packing | As per your request |
| Storage | Preserve in tight, light-resistant containers in a cool place |
| Remarks | NA |
| Custom synthesis | Available |
Edoxaban (tosylate Monohydrate) is an oral anticoagulant drug which acts as a direct factor Xa inhibitor. Edoxaban (tosylate Monohydrate) was developed by Daiichi Sankyo and approved in July 2011 in Japan for prevention of venous thromboembolisms (VTE) following lower-limb orthopedic surgery. Edoxaban (tosylate Monohydrate) was also approved by the FDA in January 2015 for the prevention of stroke and non-central-nervous-system systemic embolism.


Usage
Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke preventionIC50 Value:Target: factor XaEdoxaban is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention in patients with atrial fibrillation, an elderly population that frequently receives aspirin (ASA) and/or nonsteroidal anti-inflammatory drugs for concurrent illnesses[1].in vitro: Edoxaban PK was not affected by concomitant low-dose ASA or naproxen, but high-dose ASA incr
Company Information

Company Profile Introduction
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $45.00/5mg |
VIP6Y
|
TargetMol Chemicals Inc.
|
2026-01-15 | |
| $0.10/1KG |
VIP7Y
|
Shaanxi Dideu Medichem Co. Ltd
|
2025-09-13 | |
| $0.00/1g |
VIP2Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2024-12-25 | |
| $0.00/100G |
VIP2Y
|
Watson Biotechnology Co.,Ltd
|
2024-09-24 | |
| $35.00/1kg |
VIP3Y
|
Henan Fengda Chemical Co., Ltd
|
2024-04-19 | |
| $0.00/1kg |
VIP3Y
|
Hangzhou ICH Biofarm Co., Ltd
|
2023-07-06 | |
| $0.00/1kg |
Jiangsu Magic Biotechnology Co., Ltd
|
2023-02-20 | ||
| $0.00/1KG |
VIP4Y
|
Dingwang Technology (Wuhan) Co., Ltd.
|
2022-11-08 | |
| $0.00/1KG Ton |
VIP4Y
|
ZHUHAI HRD PHARMACEUTICAL CO., LTD.
|
2022-10-09 | |
| $0.00/25kg |
Changzhou Rokechem Technology Co., Ltd.
|
2022-08-19 |
- Since: 1996-07-16
- Address: 16F,HUICHENG COMM,839 XIAHE ROAD,XIAMEN CHINA

China